company background image
BEACONPHAR logo

Beacon Pharmaceuticals DSE:BEACONPHAR Stock Report

Last Price

৳166.50

Market Cap

৳38.2b

7D

8.3%

1Y

-32.0%

Updated

20 Jun, 2024

Data

Company Financials

Beacon Pharmaceuticals PLC

DSE:BEACONPHAR Stock Report

Market Cap: ৳38.2b

BEACONPHAR Stock Overview

Engages in the producing and promoting of pharmaceuticals finished formulations, lifesaving intravenous fluids, active pharmaceutical ingredients, bio-tech products, and genetic engineering products in Bangladesh and internationally.

BEACONPHAR fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health2/6
Dividends1/6

Beacon Pharmaceuticals PLC Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Beacon Pharmaceuticals
Historical stock prices
Current Share Price৳166.50
52 Week High৳288.90
52 Week Low৳133.60
Beta-0.38
11 Month Change4.85%
3 Month Change-24.04%
1 Year Change-32.04%
33 Year Change31.21%
5 Year Change728.36%
Change since IPO92.96%

Recent News & Updates

Recent updates

Shareholder Returns

BEACONPHARBD PharmaceuticalsBD Market
7D8.3%4.2%3.0%
1Y-32.0%-20.5%-24.2%

Return vs Industry: BEACONPHAR underperformed the BD Pharmaceuticals industry which returned -22.5% over the past year.

Return vs Market: BEACONPHAR underperformed the BD Market which returned -25.8% over the past year.

Price Volatility

Is BEACONPHAR's price volatile compared to industry and market?
BEACONPHAR volatility
BEACONPHAR Average Weekly Movement7.1%
Pharmaceuticals Industry Average Movement6.8%
Market Average Movement5.4%
10% most volatile stocks in BD Market7.6%
10% least volatile stocks in BD Market3.4%

Stable Share Price: BEACONPHAR's share price has been volatile over the past 3 months.

Volatility Over Time: BEACONPHAR's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of BD stocks.

About the Company

FoundedEmployeesCEOWebsite
20013,872Mohammad Karimwww.beaconpharma.com.bd

Beacon Pharmaceuticals PLC engages in the producing and promoting of pharmaceuticals finished formulations, lifesaving intravenous fluids, active pharmaceutical ingredients, bio-tech products, and genetic engineering products in Bangladesh and internationally. The company offers general, oncology, chronic care, and biotech products. It also provides various therapeutic products that include anticancer, cardiovascular, gastrointestinal, antibiotics, anti-coagulants, protein supplements, muscle relaxant, anti-histamine, analgesics, and NSAIDS, as well as norepinephrine injection, anticoagulant, pain killer, antiemetic, antibiotic, calcium supplement, hyper acidity, etc. In addition, the company offers contract and toll manufacturing services.

Beacon Pharmaceuticals PLC Fundamentals Summary

How do Beacon Pharmaceuticals's earnings and revenue compare to its market cap?
BEACONPHAR fundamental statistics
Market cap৳38.16b
Earnings (TTM)৳465.98m
Revenue (TTM)৳9.89b

82.5x

P/E Ratio

3.9x

P/S Ratio

Is BEACONPHAR overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BEACONPHAR income statement (TTM)
Revenue৳9.89b
Cost of Revenue৳4.91b
Gross Profit৳4.99b
Other Expenses৳4.52b
Earnings৳465.98m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.02
Gross Margin50.42%
Net Profit Margin4.71%
Debt/Equity Ratio165.4%

How did BEACONPHAR perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

56%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.